Administration of docosahexaenoic acid before birth and until aging decreases kainate-induced seizures in adult zebrafish

Brain Research Bulletin

Volumn 88, Issue 5, 2012, Pages 467-470

  Sierra, Saleta ^a   Alfaro, Juan M ^a   Sánchez, Sonia ^a   Burgos, Javier S ^a  

^a BioPharma Division   (Spain)

Author keywords

Aging; DHA; Epilepsy; Kainate; Pre spawning; PUFA

Indexed keywords

ANTICONVULSIVE AGENT; DOCOSAHEXAENOIC ACID; KAINIC ACID;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BIRTH; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; EPILEPTIC STATE; FEMALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROGENY; SEIZURE; SPAWNING;

AGING; ANIMALS; DOCOSAHEXAENOIC ACIDS; EMBRYO, NONMAMMALIAN; FEMALE; KAINIC ACID; MALE; SEIZURES; ZEBRAFISH;

EID: 84862573604     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2012.04.007     Document Type: Article

References (24)

1. Alfaro J.M., Ripoll-Gomez J., Burgos J.S. Kainate administered to adult zebrafish causes seizures similar to those in rodent models. European Journal of Neuroscience 2011, 33:1252-1255.
2. Bailey E.E., Pfeifer H.H., Thiele E.A. The use of diet in the treatment of epilepsy. Epilepsy & Behavior 2005, 6:4-8.
3. Best J.D., Alderton W.K. Zebrafish: an in vivo model for the study of neurological diseases. Neuropsychiatric Disease and Treatment 2008, 4:567-576.
4. Blondeau N., Widmann C., Lazdunski M., Heurteaux C. Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience 2002, 109:231-241.
5. Bromfield E., Dworetzky B., Hurwitz S., Eluri Z., Lane L., Replansky S., Mostofsky D. A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy & Behavior 2008, 12:187-190.
6. Cunnane S.C., Musa K., Ryan M.A., Whiting S., Fraser D.D. Potential role of polyunsaturates in seizure protection achieved with the ketogenic diet. Prostaglandins Leukotrienes and Essential Fatty Acids 2002, 67:131-135.
7. DeGiorgio C.M., Miller P., Meymandi S., Gornbein J.A. n-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study. Epilepsy & Behavior 2008, 13:681-684.
8. Fraser D.D., Hoehn K., Weiss S., MacVicar B.A. Arachidonic acid inhibits sodium currents and synaptic transmission in cultured striatal neurons. Neuron 1993, 11:633-644.
9. Gilby K.L., Jans J., McIntyre D.C. Chronic omega-3 supplementation in seizure-prone versus seizure-resistant rat strains: a cautionary tale. Neuroscience 2009, 163:750-758.
10. Haag M. Essential fatty acids and the brain. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 2003, 48:195-203.
11. Lukiw W.J., Bazan N.G. Docosahexaenoic acid and the aging brain. Journal of Nutrition 2008, 138:2510-2514.
12. McLennan P., Howe P., Abeywardena M., Muggli R., Raederstorff D., Mano M., Rayner T., Head R. The cardiovascular protective role of docosahexaenoic acid. European Journal of Pharmacology 1996, 300:83-89.
13. Polozova A., Gionfriddo E., Salem N. Effect of docosahexaenoic acid on tissue targeting and metabolism of plasma lipoproteins. Prostaglandins Leukotrienes and Essential Fatty Acids 2006, 75:183-190.
14. Relton J.K., Strijbos P.J., Cooper A.L., Rothwell N.J. Dietary N-3 fatty acids inhibit ischaemic and excitotoxic brain damage in the rat. Brain Research Bulletin 1993, 32:223-226.
15. Schlanger S., Shinitzky M., Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 2002, 43:103-104.
16. Shorvon S.D. The epidemiology and treatment of chronic and refractory epilepsy. Epilepsia 1996, 37(Suppl 2):S1-S3.
17. Sprecher H. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochimica et Biophysica Acta 2000, 1486:219-231.
18. Stewart A.M., Desmond D., Kyzar E., Gaikwad S., Roth A., Riehl R., Collins C., Monnig L., Green J., Kalueff A.V. Perspectives of zebrafish models of epilepsy: what, how and where next?. Brain Research Bulletin 2012, 87:135-143.
19. Taha A.Y., Jeffrey M.A., Taha N.M., Bala S., Burnham W.M. Acute administration of docosahexaenoic acid increases resistance to pentylenetetrazol-induced seizures in rats. Epilepsy & Behavior 2010, 17:336-343.
20. Voskuyl R.A., Vreugdenhil M., Kang J.X., Leaf A. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. European Journal of Pharmacology 1998, 341:145-152.
21. Vreugdenhil M., Bruehl C., Voskuyl R.A., Kang J.X., Leaf A., Wadman W.J. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:12559-12563.
22. Xiao Y., Li X. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Research 1999, 846:112-121.
23. Yehuda S., Carasso R.L., Mostofsky D.I. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. European Journal of Pharmacology 1994, 254:193-198.
24. Yuen A.W., Sander J.W., Fluegel D., Patsalos P.N., Bell G.S., Johnson T., Koepp M.J. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy & Behavior 2005, 7:253-258.